The US FOP drugs market size is USD xx billion in 2019 and projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder in which muscle tissue and connective tissue such as tendons and ligaments are replaced by bone, forming bone outside the skeleton (extra-skeletal or heterotopic bone) which restricts the movement of that part of the body. This disorder most often starts in early childhood and it begins from the shoulders and neck, then it goes down through the rest of the body, as patients gets older the bone replaces more and more of soft tissue and its progression vary from person to person. The rise in market value can be attributed to the introduction of new treatments and therapies and development in the healthcare expenditure and the government support for the research & development for new and better treatment have fuelled the market growth.
Rising demand for new treatment and therapies can act as a market driver. Increasing awareness regarding Fibrodysplasia Ossificans Progressiva and its treatment is also accelerating the market growth. Government support for the research & development for new and better treatment can enhance the growth of this market. Rising healthcare expenditure will also boost the market growth